Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08GYO
|
||||
Former ID |
DAP000986
|
||||
Drug Name |
Procarbazine
|
||||
Synonyms |
Ibenzmethyzin; Ibenzmethyzine; MBH; MIH; Natulan; Natulanar; PCX; Procarbazin; Procarbazina; Procarbazinum; Procarbazin [German]; Procarbazine Monohydrochloride; CB 400-497; Indicarb (TN); Matulane (TN); Natulan (TN); Procarbazina [INN-Spanish]; Procarbazine (INN); Procarbazine [INN:BAN]; Procarbazinum [INN-Latin];Ro 4-6467; SRI-10847; Ro 4-6467/1; N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine; N-Isopropyl-4-[(2-methylhydrazino)methyl]benzamide; P-(2-Methylhydrazinomethyl)-N-isopropylbenzamide; N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide; P-(N'-Methylhydrazinomethyl)-N-isopropylbenzamide; N-(1-Methylethyl)-4-[(2-methylhydrazino)methyl]benzamide; N-Isopropyl-alpha-(2-methylhydrazino)-p-toluamide; N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide; Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)-(9CI); 1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine; 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine; 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide; 4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticancer Agents
|
||||
Company |
Sigma-Tau Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H19N3O
|
||||
InChI |
InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16)
|
||||
InChIKey |
CPTBDICYNRMXFX-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 671-16-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9606, 5227622, 7980389, 8153026, 10532324, 11112335, 11446055, 11451557, 11467140, 11468260, 11486848, 15195970, 29223993, 46507706, 47440427, 47736658, 47810931, 48259429, 48414372, 48416472, 49699412, 49857646, 50100422, 53790978, 57288818, 57322522, 60975981, 75023517, 92309185, 92720556, 93166341, 96025109, 103411217, 104224963, 104307787, 119525894, 125564988, 126619890, 126653077, 126667406, 127660052, 134338256, 134977726, 136342514, 137001449, 140349398, 144076104, 144212055, 152030630, 160655721
|
||||
SuperDrug ATC ID |
L01XB01
|
||||
SuperDrug CAS ID |
cas=000671169
|
||||
Target and Pathway | |||||
Target(s) | DNA | Target Info | [536874] | ||
References | |||||
Ref 538480 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 016785. | ||||
Ref 542298 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7278). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.